Why this new shingles shot might help you remember better

Original Title

The recombinant shingles vaccine is associated with lower risk of dementia

Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms

Summary

Scientists compared two shingles vaccines: the old one and a newer, stronger one. They found people who got the new one were less likely to get dementia in the next six years.

Sign up to see full results

Get access to research results, context, and detailed analysis.

Surprising Findings

The recombinant shingles vaccine showed stronger protection against dementia than two other common vaccines (flu and Tdap), even though those are also given to older adults.

Most people assume all vaccines offer similar 'general health' benefits — but this study shows the shingles vaccine has a unique, specific effect on dementia risk, not just a side effect of being vaccinated.

Practical Takeaways

If you're 50+, ask your doctor about the recombinant shingles vaccine (Shingrix) — it’s already recommended for shingles prevention, and this study suggests it may also delay dementia.

high confidence

Unlock Full Study Analysis

Sign up free to access quality scores, evidence strength analysis, and detailed methodology breakdowns.